IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.315
EU - Europa 3.300
AS - Asia 2.939
SA - Sud America 707
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 143
OC - Oceania 8
Totale 14.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.085
SG - Singapore 945
IT - Italia 753
VN - Vietnam 697
BR - Brasile 546
RU - Federazione Russa 519
CN - Cina 469
UA - Ucraina 388
DE - Germania 297
IE - Irlanda 240
SE - Svezia 226
HK - Hong Kong 220
FR - Francia 204
FI - Finlandia 170
GB - Regno Unito 170
DK - Danimarca 138
CA - Canada 136
BD - Bangladesh 110
TR - Turchia 108
IN - India 87
KR - Corea 75
MX - Messico 65
NL - Olanda 63
AR - Argentina 52
MA - Marocco 46
CI - Costa d'Avorio 41
IQ - Iraq 38
PL - Polonia 28
PK - Pakistan 27
EC - Ecuador 24
ZA - Sudafrica 24
ID - Indonesia 22
CO - Colombia 21
ES - Italia 20
JP - Giappone 20
VE - Venezuela 20
AT - Austria 19
PH - Filippine 19
BE - Belgio 17
CL - Cile 16
UZ - Uzbekistan 14
LT - Lituania 11
SA - Arabia Saudita 11
TN - Tunisia 11
PY - Paraguay 10
PE - Perù 8
TW - Taiwan 8
AU - Australia 7
IL - Israele 7
JO - Giordania 7
HN - Honduras 6
IR - Iran 6
RS - Serbia 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CH - Svizzera 5
KZ - Kazakistan 5
MY - Malesia 5
UY - Uruguay 5
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
RO - Romania 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
UG - Uganda 3
BH - Bahrain 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GT - Guatemala 2
HU - Ungheria 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
PR - Porto Rico 2
QA - Qatar 2
SR - Suriname 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
Totale 14.401
Salva come PNG Salva come JPEG
Città #
Ashburn 1.244
Dallas 1.031
Singapore 579
Jacksonville 393
Chandler 388
San Jose 363
Council Bluffs 261
Fairfield 257
Dublin 233
Boardman 229
Ho Chi Minh City 223
Hong Kong 211
New York 186
Hanoi 167
Wilmington 150
Woodbridge 144
The Dalles 133
Los Angeles 127
Beijing 126
Lauterbourg 109
Moscow 109
Seattle 104
Munich 102
Houston 101
Ann Arbor 97
Helsinki 92
Princeton 91
Lawrence 87
Des Moines 85
San Mateo 82
Milan 74
Cambridge 66
Montréal 62
Centro 59
Hefei 53
São Paulo 50
Mcallen 49
Santa Clara 48
Ancona 45
Orem 42
Abidjan 41
Montreal 41
San Diego 41
Buffalo 38
Chicago 38
Da Nang 32
Mexico City 31
Turin 29
Warsaw 26
Chennai 24
Washington 24
Haiphong 22
Shanghai 20
Amsterdam 19
Atlanta 18
Frankfurt am Main 17
London 17
Pune 17
Rome 17
Brussels 16
Florence 16
Guangzhou 16
Redmond 16
Tokyo 16
Baghdad 15
Stockholm 15
Hải Dương 14
Johannesburg 14
Phoenix 14
Rio de Janeiro 14
Tashkent 14
Wuhan 14
Brooklyn 13
Denver 13
Manchester 13
Nuremberg 13
Boston 12
Brasília 12
Miano 12
Poplar 12
Saint Petersburg 12
Thái Bình 12
Castelfidardo 11
Dhaka 11
Salvador 11
Ankara 10
Bologna 10
Columbus 10
Curitiba 10
Lahore 10
Norwalk 10
Salt Lake City 10
San Francisco 10
Toronto 10
Turku 10
Chiaravalle 9
Belo Horizonte 8
Buenos Aires 8
Charlotte 8
Guayaquil 8
Totale 9.056
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 346
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 256
Expanding the mosaic functions of intravenous immunoglobulin 241
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 218
7th International Immunoglobulin Conference: Immunomodulation. 207
Colonna vertebrale. Midollo spinale. Imaging 206
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 189
La scelta della maternità. Una guida alla decisione per le donne con LES 186
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 182
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 178
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 173
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 171
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 170
Cardiac involvement in polymyositis and dermatomyositis 158
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 158
Overexpression of the cytokine BAFF and autoimmunity risk 157
Intravenous immunoglobulin as a therapy for autoimmune conditions 155
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 154
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 153
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 153
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 153
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 147
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 147
6th International Immunoglobulin Symposium: poster presentations. 145
Subcutaneous IgG in the Myositis Spectrum Disorders 143
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 143
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 142
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 142
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 141
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 140
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 140
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 138
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 138
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 137
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 136
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 135
Alarmins in autoimmune diseases 134
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 133
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 133
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 131
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 129
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 128
Dr. Guerra, et al reply 128
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 126
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 125
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 124
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 121
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 121
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 121
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 120
Bullous SLE: response to methotrexate and relationship with disease activity 119
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 118
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 118
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 117
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 116
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 115
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 112
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 111
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 111
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 110
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 109
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 109
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 109
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 108
Ultrasonographic contrast-enhanced study of sicca syndrome 108
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 108
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 107
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 103
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 102
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 102
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 102
Exposome: Epigenetics and autoimmune diseases 101
La terapia immunosoppressiva nelle miositi refratttarie 100
Risk factors for Sjögren's syndrome: a case-control study. 100
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions 98
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 98
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 98
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 98
Subcutaneous immunoglobulins in ocular myositis. 97
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 97
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 96
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 95
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 94
The European Society for Immunodeficiencies (ESID) registry 2014 94
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 93
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 93
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 93
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 92
Polyautoimmunity Reflecting Immune Dysregulation in Common Variable Immunodeficiency 92
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 92
Machine learning application in autoimmune diseases: State of art and future prospectives 92
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study 92
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 90
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 90
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 90
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 90
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 88
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 87
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 85
Lessons from the "Euro-Lupus Cohort". 85
Totale 12.876
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022645 0 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024915 158 40 56 123 143 188 18 34 10 32 19 94
2024/20251.759 134 170 75 31 66 94 178 91 326 158 180 256
2025/20266.977 306 878 629 654 695 448 1.140 641 536 606 191 253
2026/2027454 309 145 0 0 0 0 0 0 0 0 0 0
Totale 14.648